IISc Foundation and IndusSetu Partner to Advance Global Medical Research and Equity
The Indian Institute of Science (IISc) Foundation and IndusSetu Global Foundation have signed a Memorandum of Understanding to collaborate on advancing medical research, translational science, and equitable healthcare access, announced in a press release.
The partnership, formalized on September 4, 2025, connects institutions in California, Texas, and Bengaluru to share research, talent, and innovation in healthcare. It will include global programs such as symposia, innovation showcases, and expert panels centered on affordable healthcare and MedTech commercialization.
The collaboration also aims to support women's health, oncology, clinical training, and equity-driven research through the IISc Tata Medical School and Bagchi-Parthasarathy Hospital. Both organizations plan to establish a Founders Circle to bring together donors and partners committed to expanding accessible medical innovation.
According to the announcement, the partnership seeks to build a global bridge between India’s scientific community and Silicon Valley’s innovation ecosystem to accelerate the translation of research into practical healthcare solutions.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Machine-learning models predict death risk after heart attack better than standard score Nov 13 Redesign Health launches growth equity practice for clinical AI Nov 13 Dyania Health and Nvidia bring clinical reasoning AI inside hospital networks Nov 13 Betterness extends seed round to $3.5M for Miami AI health networks Nov 13 93% of health systems now use AI, CHIME survey findsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
HistoIndex and A*STAR Partner on Fibrosis Drug Evaluation
Google Expands Health AI Work in Singapore
BioMap Announces 11 AI Life Science Collaborations
AstraZeneca and Oracle Partner on AI for Clinical Trials
BioStack Raises $9.5 Million for Medical AI Data Network
Daily AI Brief: the AI news that matters, in your inbox.